Skip to main content
Novo Nordisk A/S (CPH:NOVO.B)
Denmark flag Denmark · Delayed Price · Currency is DKK
342.50
-6.00 (-1.72%)
Sep 29, 2025, 1:20 PM CET

Novo Nordisk Revenue

Novo Nordisk had revenue of 76.86B DKK in the quarter ending June 30, 2025, with 12.93% growth. This brings the company's revenue in the last twelve months to 311.94B, up 20.90% year-over-year. In the year 2024, Novo Nordisk had annual revenue of 290.40B with 25.03% growth.

Revenue (ttm)
311.94B
Revenue Growth
+20.90%
P/S Ratio
4.96
Revenue / Employee
3.98M
Employees
77,349
Market Cap
1,548.54B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Coloplast 27.87B
Genmab 23.16B
Demant 22.59B
ALK-Abelló 5.86B
H. Lundbeck 23.52B
Zealand Pharma 9.11B
Ambu A/S 5.96B
Bavarian Nordic 6.46B
Revenue Rankings

Novo Nordisk News

More News